Translational & Clinical Research
In terms of translational and clinical research, the IOR has a strict collaboration with the Oncology Institute of Southern Switzerland (IOSI - EOC), playing a crucial role in driving innovation in cancer research and treatment, and is essential for offering cutting-edge cancer therapies.
Through this highly dynamic and fruitful collaboration, including numerous joint working groups, there is a constant exchange of ideas, ensuring that new discoveries from laboratory research at IOR are rapidly translated into clinical trials at IOSI.
The preclinical research conducted at IOR and the Institute for Research in Biomedicine (IRB) serves as the foundation for translational and clinical studies, potentially leading to the development of new therapeutic tools for patients. Moreover, the collaboration enables researchers from both translational and basic science laboratories to benefit from the expertise of clinicians, fostering discussions that significantly impact everyday clinical practice.
Many of the clinical studies currently underway at IOSI, particularly in areas such as prostate cancer, lymphoma, new pharmaceuticals, and breast cancer, have their roots in discoveries made at IOR laboratories. These studies often feature a strong translational component, carried out in collaboration with IOR and IRB, with the goal of investigating treatment mechanisms, resistance, and the application of immunotherapy in clinical practice.
Related news
Prostate cancer: new discovery at IOR on resistance to hormonal therapies
Prostate cancer: IOR contributes to significant advancement
IOR and IOSI gold medal in lymphomas
Krebsliga awards the Robert Wenner prize to Davide Rossi at IOR
Better poison dosages for better prostate cancer therapies
New discovery at the IOR on mechanisms leading to the spread of metastases
IOR lays the foundation for a new clinical trial against lymphomas
Interfering with gene expression to fight cancer
Fighting leukemia starting from its evolution. A new ERC-funded research project at the IOR
